2021 SAPA Annual Conference Building a Healthier Future

2021 SAPA Annual Conference | October 1 - 2, 2021

Friday & SaturdayOctober 1 & 2, 2021Virtual Conference

2021 SAPA Annual Conference

h t t p s : / / s a p a w e b . o r g

Sino-American PharmaceuticalProfessionalsAssociation

Building a Healthier Future

Title Sponsors

Science u Education u Collaboration u Career

This year’s annual conference is co-organized with the SAPA-DC Chapter


Continue to connect the dots

Annual ConferenceDistinguished speakers and panelistsDiverse and rich learning contentExplore opportunitiesNot to be missedVirtually

Registration is now openhttps://sapaweb.org/sapa2021AC-registration/

• General audience: $25• Student and Postdocs: $10• SAPA Members: Free• Promotional codes are available where applicable

https://sapaweb.org/sapa2021AC-registration/


Building a Healthier FutureWelcome to 2021 SAPA Annual Conference

On behalf of the Sino-American Pharmaceutical Professionals Association (SAPA),we cordially invite you to participate in the 2021 SAPA Annual Conference, to be heldonline due to the continued COVID-19 pandemic situation using Zoom webinar formatfrom October 1 to 2, 2021.

The SAPA Annual Conference is a great platform for participants to share knowledge,wisdom, and viewpoints on important issues and current trends in academic researchand pharma and biotech industries. Our events feature presentations and paneldiscussions by distinguished speakers and panelists from academia, industry, andregulatory authorities, to provide opportunities for scientific exchange, public healtheducation, networking, career development, and business collaborations. Prior topandemic this flagship event was usually held at the DoubleTree by Hilton Hotel andConference Center, Somerset, New Jersey in the past several years, and each yearattracted over 1,000 attendees. Due to continued pandemic situation and to ensurethe safety of our speakers and participants, we have decided to host this yearsannual conference via virtual format again. Building on the past success and theconvenience of the online event we got distinguished speakers and participants allover the world without geological restrictions.

The theme of this year’s annual conference is “Building a Healthier Future”. Thisdoes not only showcase the ambition and mission of academic research, pharma andbiotech industry, but also reflect our individual desire and organizational direction tofurther develop a stronger SAPA.

We are very grateful to have the team from SAPA-DC under the leadership of CharlesLi to join force and actively participate this year’s annual conference planning, a greatexample towards greater collaboration and realize our dream of OneSAPA.

This year’s conference will cover diverse topics including the following:• Plenary sessions featuring distinguished scholars and leaders to showcase

the latest trend of the pharma development;• Legal and Regulatory Issues, Challenges, and Opportunities in the Era of

COVID-19;• Public Health Challenges and Implications;• Career Development Spotlight: “BE ON!”;• Frontiers in Drug Discovery and Development: From Academia to Industry;• Healthcare Investment Trend and Transformative Deal Cases;• Cross the Finish Line: Multiple Team Efforts in Drug Development at Clinical

Stage;• Challenges and Opportunities in Developing New Drugs and Treatment

Modalities in CMC;• Update and Advancement in Precision Medicine, Clinical Diagnostics and

Medical Device;• Virtual Reception, Lunch and Learn, and Happy Hours.

We look forward to seeing you virtually at the SAPA Annual Conference.

Sincerely yours,

John Sun, PhD, MBAGlobal Program Lead, NovartisSAPA President2021 SAPA Annual Conference Chair

Xiaodong Chen, PhDDirector of CMC Operations, Roivant SciencesSAPA President-Elect2021 SAPA Annual Conference Co-Chair


Partial List of Speakers Presented at Previous SAPA EventsAcademic Institutions:• Prof. Martin Chalfie, Nobel Laureate, Columbia University (2019 SAPA Lifetime Achievement Awardee)

• Prof. Joachim Frank, Nobel Laureate, Columbia University (2018 SAPA Lifetime Achievement Awardee)

• Prof. David Ho, Rockefeller University, CEO of Aaron Diamond AIDS Research Center (2018 SAPA Distinguished Achievement Awardee)

• Prof. Dudley Herschbach, Nobel Laureate, Harvard University• Prof. Jack Szostak, Nobel Laureate, Harvard Medical School• Prof. Craig Mello, Nobel Laureate, University of Massachusetts Medical Center• Prof. Bruce Beutler, Nobel Laureate, University of Texas Southwestern Medical Center• Prof. K. Barry Sharpless, Nobel Laureate, Scripps Research Institute• Prof. Baruch S. Blumberg, Nobel Laureate, Fox Cancer Center• Prof. Ferenc Avraham Hershko, Nobel Laureate, Israel Institute of Technology• Prof. Yigong Shi, Dean of Life Science, Tsinghua University, Beijing, China• Prof. Yibin Kang, Princeton University; President-elect, the Metastasis Research Society• Prof. Shan Lu, MD, PhD, Professor, University of Massachusetts Medical School• Dr. Xiaodong Wang, Director of National Institute of Biological Sciences and Co-Founder of BeiGene, Beijing, China (2019 SAPA Distinguished Achievement Awardee)

• Prof. Virginia Man-Yee Lee, PhD, John H. Ware 3rd Professor in Alzheimer’s Research, Director of the Center for Neurodegenerative Disease Research and Co-Director of the Marian S. Ware Alzheimer Drug Discovery Program, University of Pennsylvania (2020 SAPA Lifetime Achievement Awardee)

Industry & Health Authority:• Dr. P. Roy Vagelos, MD, Retired Chairman & CEO, Merck & Co, Inc., Chairman of the Board, Regeneron Pharmaceuticals, Inc.

• Mr. Kenneth C. Frazier, Chairman and Chief Executive Officer, Merck & Co., Inc.• Dr. Peter Stein, MD, Director, CDER, Office of New Drugs, Immediate Office, US FDA • Dr. Peter Marks, Director, CBER, US FDA• Dr. Theresa Mullin, Director, office of strategic program, FDA/CDER and Chair of ICH management committee

• Dr. Rupert Vessey, PhD, EVP and President, Research and Early Development, BMS

• Dr. Dean Li, MD, PhD, SVP, Discovery Science and Translational Medicine, Merck Research Laboratories

• Dr. Mathai Mammen, MD, PhD, Global Head of R&D, Janssen Pharmaceutical Companies of Johnson & Johnson

• Dr. Binodh DeSilva, PhD, Vice President, Leads Development & Optimization, Bristol Myers Squibb (2020 SAPA Distinguished Achievement Awardee)

• Dr. Andrew Chan, MD, PhD, Senior VP Research Biology, Genentech • Dr. Josh Ghaim, CTO, Johnson & Johnson, Family of Consumer Companies• Dr. Axel Hoos, Senior Vice President, Oncology R&D, GSK• Dr. Sandra Leung, Executive Vice President, General Counsel and Corporate Secretary, BMS• Mr. Isaac Blech, Managing Director, 21st Century Investors Group• Dr. Mathias Hukkelhoven, Senior Vice President, Bristol-Myers Squibb• Dr. David Lebwohl, Senior Vice President, Novartis• Dr. Deborah Dunsire, CEO, Millennium-Takeda• Dr. Cathryn Clary, Head, US Medical & Chief Scientific Officer, Novartis Pharmaceuticals • Dr. Joe Camardo, Senior Vice President, Global Medical Affairs, Celgene Corporation• Dr. Michele Cleary, VP, Head of Clinical Translational Technologies & Operations, BMS• Dr. Paul Deutsch, VP, Head of Translational Medicine & Early Development, Sanofi• Dr. JC Gutierrez-Ramos, Senior Vice President, Chief Scientific Officer, Pfizer• Dr. Ronald Krall, Sr. VP, World Wide Development and Chief Medical Officer, GlaxoSmithKline• Dr. Rich Tillyer, Sr. VP, Head of Discovery & Preclinical Sciences, Merck Research Laboratories• Dr. Lee Babiss, Head of Global Pharma Research, Roche• Dr. Robert R. Ruffalo, President, Wyeth Research• Dr. Alan Palkowitz, VP, Discovery Chemistry Research & technology, Eli Lilly & Company• Dr. Ge Li, Founder and CEO, Wuxi AppTec (2018 SAPA Distinguished Achievement Awardee)• Dr. Dequan Ren, Deputy Commissioner, State Food and Drug Administration of China (SFDA)• Dr. Stephen Wilson, Director, Division of Biometrics, FDA• Dr. Greg Geba, Former Director, Office of Generic Drugs at CDER, FDA• Dr. Joshua Ghaim, Chief Technology Officer, Johnson & Johnson Family of Consumer Companies• Mr. Lawrence Y. Tian, Chairman, CIFCO International Group• Dr. Lawrence X. Yu, Deputy Director, Office of Pharmaceutical Quality at CEDR, FDA (2019 SAPA Distinguished Achievement Awardee)

Speaker titles and affiliations were at the time of presentations.


2021 SAPA Annual Conference at a Glance

Time Code Session Topics

1 – 3 pm P1 Plenary Session I

3 – 4 pm CF Virtual Career Fairs

Parallel Sessions:

4 – 5:30 pm A Legal

4 – 5:30 pm B Public Health Policies

4 – 5:30 pm C Career Development

9 – 10:00 pm D Title Sponsor Network Session

Friday, October 1st Saturday, October 2nd

All times listed are Eastern Day Time.

Time Code Session Topics

9 am – 12:30 pm P2 Plenary Session II

12:30 – 1:30 pm E Lunch and Learn Connection

Parallel Sessions:

1:30 – 5 pm F Drug Discovery and Early Development

1:30 – 5 pm G Healthcare Investment and Business Development

1:30 – 5 pm H Clinical Development, Data Sciences and Regulatory Affairs

1:30 – 5 pm I CMC and Quality

1:30 – 5 pm J Precision Medicine, Clinical Diagnostics, and Medical Device

5 – 6 pm K Interactive Breakout Sessions




Speakers and Panelists at the 2021 SAPA Annual Conference (1 of 3)

Alberto Grignolo, PhDCorporate VP, Parexel

International

Bojana Berić-Stojšić, MD, PhD, MA

Asso. Prof. and Program Dir of MPH Program, School of Pharmacy & Health Sciences, Fairleigh Dickinson University

Caleb Lee, MD, PhDSenior Director, Global

Oncology Clinical Development, Daiichi

Sankyo, Inc.

Dalvir Gill, PhDCEO, TransCelerate

Biopharma Inc.

Julie CampbellFounder and Chief Storytelling Officer,

Central Stage Connection

Jingxi Chu, JD, MSDeputy General

Counsel, Nanova, Inc.

Michael Druckman, JD

Partner, Hogan Lovells LLP

Scott FilosiCEO of Hengrui USA &

Hengrui Europe

Shishir Gadam, PhDVP, Cell Therapy

Global Manufacturing Sci. & Tech, BMS

Oliver Nianfeng Ju, EMBA

Chairman and CEO, Porton

Kenneth Kaitin, PhDProfessor and Senior Fellow, Center for the

Study of Drug Development, Tufts University School of

Medicine

San Kiang, PhDChief Technology

Officer, J-star/Porton



Ke Liu, MD, PhDSenior Vice President,

Head of Regulatory Affairs & Strategy at Sana Biotechnology,

Inc.

Rao V. Mantri, PhD, MBA

VP & Head, Drug Product Development

BMS

Jay Mei, PhDFounder, Chairman &

CEO, AntengeneCorporation

Daniel RobertsSenior Specialist,

Pharmaceutical and Biotechnology Practice,

Hogan Lovells

Haojing Rong, PhDVP of Preclinical

Development, KymeraTherapeutics

Kenneth A. Rosenberg, JD

Partner, Labor and Employment, Fox Rothschild LLP

Mike Sheldon, PhDSenior Director,

Scientific Affairs, Infinity BiologiX

Yue Shentu, PhDDistinguished Scientist / Exec Dir., Biostas and

Research Decision Sciences, Glb Clin Dev,

Merck

Elizabeth Litten, JDChief Privacy & HIPAA

Compliance Officer, Corporate and Office of

General Counsel Departments & Partner of Fox Rothschild LLP

Jonathan Liu, PhD, DVM

Chief Executive, Bio-Island Initiative &

Chairman of the Board, BeiGene Guangzhou

Biologics, Ltd. Co.

Duxin Sun, PhDProfessor of Pharmacy

and Pharmaceutical Sciences, College of

Pharmacy, University of Michigan

Lisong Sun, MS Senior Software

Engineer at Canfield Scientific



Jin Wang, PhDProfessor in

Pharmacology, Department of

Pharmacology and Chemical Biology at

Baylor College of Medicine

John Wang, PhDHead of External

Innovation, Immunology, Eli Lilly

and Company

Lai Wang, PhDGlobal Head of R&D,

BeiGene

Xuqiong (Joanna) Wu, PhD, JD

Attorney, biotech incubator company

Jingjun Yin, PhDExecutive Director,

Process Research & Development, Merck &

Co., Inc.

Litao Zhang, PhDGlobal Head of

Discovery Tech & Molecular

Pharmacology, The Janssen

Pharmaceutical Companies of Johnson

& Johnson

Lili Zheng, MSPartner, International

Tax, Asia Pacific Cross-Border Services

Leader, Deputy Managing Partner – US

Chinese Services Group, Deloitte Tax

LLP

Zhi-Fu Tao, PhDPrincipal Research

Scientist II, Oncology Discovery, Abbvie Inc.

Steven Townsend, PhD

Associate Professor of Chemistry, Vanderbilt

University

John Tsai, MDHead of Global Drug

Development and CMO, Novartis

Yaji Xu, PhDSr. Staff Biostatistician, Biostatistics, Illumina

Fang Zhang, PhDExecutive Director,

China Business Development, BMS


P11 pm – 3 pm

FridayOctober 1

Sino

-Ame

rican

Pha

rmac

eutic

al Pr

ofess

ionals

Ass

ociat

ion

Plenary Session


Beyond the Trend and Landscape of New Drug Development: Breakthrough Discoveries and TechnologiesAt this plenary session we will hear from the world-renowned and authoritative scholars and leaders ontheir elucidation of the evolving landscape for new drug development and the trends of pharma R&D, andto learn how to build a more diverse, equitable and inclusive future where everyone belongs. We will alsolearn the new advancement of the cutting-edge and innovative technology platforms into therapeuticapplications across multiple areas.


CF3 pm – 4 pm

FridayOctober 1

Sino

-Ame

rican

Pha

rmac

eutic

al Pr

ofess

ionals

Ass

ociat

ion

Virtual Career

Fair


Sponsor Booths and Virtual Career FairMany sponsors had hoped to meet the conference attendees in person at the Annual Conference whenwe originally planned to host this year’s Annual Conference at the DoubleTree Conference Center.Although we cannot do it face-to-face in person this time, we are planning a series of virtual rooms toprovide direct and interactive opportunities for the conference attendees to learn the newest developmentand advancement of our sponsors. Several sponsors are seeking talents to join their teams so this is agreat opportunity for the job candidates to find the next growth opportunity. Take a break between thesessions and visit these virtual rooms, and serendipitous moments are awaiting for you. We alsoencourage you to visit the SAPA Career Center for newly posted job opportunities:https://sapaweb.org/career-center/

https://sapaweb.org/career-center/


A4 pm – 5:30 pm

FridayOctober 1

Sino

-Ame

rican

Pha

rmac

eutic

al Pr

ofess

ionals

Ass

ociat

ion

Legal


Legal and Regulatory Issues, Challenges, and Opportunities in the Era of COVID-19Health care providers and life sciences companies, as well as government agencies, have been on thefront lines fighting the pandemic. The pandemic has brought many challenges as well as opportunities.This panel from in-house legal departments and law firms will discuss practical challenges involvingpolicy changes and applications at the practical and operational levels, opportunities such as newpractice areas and new remote jobs, FDA regulatory issues in vaccine approvals, as well as legal issuesrelating to “returning to work,” in particular legal considerations on vaccination mandates, disclosurerequirement, and employer/employee’s various rights and obligations, etc., from health law andemployment law perspectives.


B4 pm – 5:30 pm

FridayOctober 1

Sino

-Ame

rican

Pha

rmac

eutic

al Pr

ofess

ionals

Ass

ociat

ion

Public Health Policies


Public Health Challenges and Implications

The world is facing the most challenging public health crisis brought about by COVID-19 pandemic. In addition to medical issues related to COVID-19, it is extremely important for the public to have a clear understanding of the public health issues. The public health experts will discuss issues and policies related to the current pandemic and as well as other public health concerns.


C4 pm – 5:30 pm

FridayOctober 1

Sino

-Ame

rican

Pha

rmac

eutic

al Pr

ofess

ionals

Ass

ociat

ion

Career Development


Career Development Spotlight: “BE ON!”

In the first 30 seconds of any interaction, people make a decision about whether they care about what you have to say and whether they will continue to listen.

Are you struggling with HOW to communicate more effectively with colleagues, clients, or management? You are invited to this spotlight session, with Julie Campbell of Center Stage Connections, where you will learn how to think of yourself as an actor on the business stage. In this interactive training, Julie shares tips, tools, and techniques from her 30+ years as a professional actor and storyteller. Come away with concrete strategies for more confidence, stronger presence and greater clarity in phone calls, meetings, and presentations. Choose to be wholly invested in your message and actions, and BE ON!


D9 pm – 10 pm

FridayOctober 1

Sino

-Ame

rican

Pha

rmac

eutic

al Pr

ofess

ionals

Ass

ociat

ion

Title Sponsor NetworkSession


Virtual Reception and Happy Hours

Although we cannot hold the face-to-face reception because of the pandemic, networking happenseverywhere! Grab your favorite drink and listen to our title sponsors introduce their latest technology andtheir job opportunities. Both of them are hiring, particularly in New Jersey. Don’t miss the happy hour!

http://www.beigene.com http://www.portonpharma.com

BeiGene is a biopharmaceutical company focused on developing molecularly targeted and immuno-oncology drug candidates for the treatment of cancer.

Porton Pharma Solutions Ltd. is a leading pharmaceutical CDMO in China, providing global pharmaceutical companies and drug institutions with customized R&D.

http://www.beigene.com/

http://www.portonpharma.com/


P29 am – 12:30 pm

SaturdayOctober 2

Sino

-Ame

rican

Pha

rmac

eutic

al Pr

ofess

ionals

Ass

ociat

ion

Plenary Session


Collaborate and Innovate to Accelerate Development ProcessThe unprecedented COVID-19 pandemic presented devastating human and economical costs since lastyear, yet it presented an rare opportunity for us to challenge the traditional ways we develop drugs. Thenew wave of digital disruption in healthcare also opened the new and exciting fields and force us to thinkdifferently on modernization and transformation on how we conduct R&D in the future, which is moredata-driven and patient-centered. Cross boarder and cross industry collaboration presented newprospect to accelerate drug development process. After hearing the successful stories of our titlesponsors, we are delighted to invited a panel of chief executives to share their views and predictionsthrough their leadership lens.

Other than the drug development process, this is also a good opportunity to discuss how to developSAPA as an organization to a brighter and stronger future, acknowledge the contribution of ourvolunteers, and will also unveil the new SAPA leadership team for the coming year.


E12:30 pm – 1:30 pm

SaturdayOctober 2

Sino

-Ame

rican

Pha

rmac

eutic

al Pr

ofess

ionals

Ass

ociat

ion

Lunch and Learn

Connection


Lunch and LearnBMS: Leaders from different function units at Bristol Myers Squibb (BMS) are invited to share theirpersonal experiences working at BMS after integration and their insights on the future of the company.

Biocytogen: Dr Qingcong Lin, CEO of Biocytogen, will give a brief presentation about their innovativeantibody discovery using transgenic mouse platforms.

http://www.bms.com http://www.biocytogen.com

BMS is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Founded in 2009, Biocytogen has become a global leader in gene-edited animal and cell model production.

http://www.bms.com/

http://www.biocytogen.com/


F1:30 pm – 5 pm

SaturdayOctober 2

Sino

-Ame

rican

Pha

rmac

eutic

al Pr

ofess

ionals

Ass

ociat

ion

Drug Discovery and Early

Development


Frontiers in Drug Discovery and Development: From Academia to IndustryThe COVID-19 pandemic is reshaping the frontiers of drug discovery and development. In this session,we invited speakers from both academia and biopharma to talk about the most advanced technologiesfor discovering future therapeutic agents. New modalities such as ADC and PROTAC showing greatpromise in clinical development on challenging targets will be discussed. In addition, directed evolutionapplied in the fast development of monopiravir and islatravir (antiviral drugs for Covid-19 and HIV) willalso be covered. Furthermore, drug discovery practices in the academia that has always been thebirthplace of new technologies, will also be included.


G1:30 pm – 5 pm

SaturdayOctober 2

Sino

-Ame

rican

Pha

rmac

eutic

al Pr

ofess

ionals

Ass

ociat

ion

Healthcare Investment

and Business

Development


Healthcare Investment Trend and Transformative Deal CasesHealthcare companies around the world are witnessing a record high in healthcare funding and deal activities this year. In the first seven months of 2021, global healthcare venture funding reached $63.5 billion across 3,086 deals, according to Crunchbase. With the pandemic accelerating many aspects of the healthcare industry, investment and business development are potentially moving faster than ever before.

The SAPA Investment and Business Development session is an excellent platform for participants to hear from and connect with global pharma leaders, investors, and cutting-edge growth companies on investing and business development topics. The agenda includes featured guest speakers discussing global healthcare investment trends and transformative business development cases. Broad topics will be covered in a panel discussion afterwards. Come and join us to navigate the ever-shifting healthcare investment and business development landscape.


H1:30 pm – 5 pm

SaturdayOctober 2

Sino

-Ame

rican

Pha

rmac

eutic

al Pr

ofess

ionals

Ass

ociat

ion

Clinical Development, Data Sciences

and Regulatory

Affairs


Cross the Finish Line: Multiple Team Efforts in Drug Development at Clinical StageDrug development process is long and costly. Very small fraction of drug candidates can make to clinicalstage. Even fewer of them can achieve positive outcome in a registration clinical trial that can be filedwith regulatory health authorities for approval. Stake is high. It often can make or break a company.Vigorous study design, effective communication and close collaboration are critical to bring drug to crossthe finish line for patient’s treatment.


I1:30 pm – 5 pm

SaturdayOctober 2

Sino

-Ame

rican

Pha

rmac

eutic

al Pr

ofess

ionals

Ass

ociat

ion

CMC and Quality


Challenges and Opportunities in Developing New Drugs and Treatment Modalities in CMCNew treatment options and modalities such as antibody-drug conjugates (ADC), gene and cell therapyprovide new challenges in the CMC area in terms of developing manufacturing processes and ensuringthe quality of new drug products. In this session, experts in product development, manufacturing andquality will discuss the challenges and opportunities in formulation and process development,manufacturing and quality control for new drug products and treatment modalities. CMC scientists inanalytical, pharmaceutical and manufacturing development can all benefit from in-depth understanding ofthese challenges and start looking for new opportunities.


J1:30 pm – 5 pm

SaturdayOctober 2

Sino

-Ame

rican

Pha

rmac

eutic

al Pr

ofess

ionals

Ass

ociat

ion

Precision Medicine,

Clinical Diagnostics and Medical

Device


Update and Advancement in Precision Medicine, Clinical Diagnostics and Medical DevicePrecision medicine, clinical diagnosis and medical device are important aspects of patient care inaddition to pharmaceutical treatment. The advances in diagnostic tools have enabled the identification oftherapeutic strategies more accurately for patients than ever. Medical devices are also essential inimproving patient’s health and quality of life. Our program will bring together experts in the field to sharetheir knowledge and showcase cutting edge technologies in the field of precision medicine, clinicaldiagnosis and medical device.


K5 pm – 6 pm

SaturdayOctober 2

Sino

-Ame

rican

Pha

rmac

eutic

al Pr

ofess

ionals

Ass

ociat

ion

Breakout Sessions


Interactive Network Breakout SessionsThese interactive network sessions have become popular fixtures of the SAPA events. After the formalsessions, these are great opportunity to ask additional questions to the presenters and panelists,exchange ideas, and to build and expand personal and professional network. SAPA is a great platform tolearn new scientific advancement and technologies, and also to make new friends connections. Theseare informal sessions to all participants to get to know each other, after a long day of the events. Socome and turn on your video camera and microphone, and to open up and speak up. We looking forwardto seeing you all.


Diamond Sponsors

2021 Annual Conference Title Sponsors Strategic Sponsor

Platinum and Gold Sponsors

Sino

-Ame

rican

Pha

rmac

eutic

al Pr

ofess

ionals

Ass

ociat

ionSAPA Thanks Our Corporate Sponsors and Collaborators

Strategic Collaborators

Visit SAPA career center for job opportunities: https://sapaweb.org/career-center/

https://sapaweb.org/career-center/


SAPA Introduction

The Sino-American Pharmaceutical Professionals Association (SAPA)was established in 1993 and is headquartered in the center of thepharmaceutical corridor in New Jersey, USA. Since its inception, SAPAhas rapidly become one of the most active Chinese-Americanprofessional associations in the US.

SAPA’s members are primarily from large and mid-sized pharmaceuticaland biotech companies in the US, with areas of expertise coveringalmost every aspect of pharmaceutical research, development, andproduction.

The organization’s large membership base, with their superb scientificand technical abilities, has allowed SAPA to be a key source forknowledge exchange on the latest developments in the pharmaceutical,biotechnology, and generic drug industries.

As a non-profit organization registered in the US, SAPA receivesgenerous sponsorship and support from numerous multinationalcompanies in the US and overseas. SAPA will continue to provide abroad platform for scientific and technical discussion, education andtraining, entrepreneurship, and business collaboration in academia andthe pharmaceutical industry.

SAPA Sites and Chapters• SAPA-HQ (Headquarter): New Jersey, USA• SAPA-NE (New England Chapter): Boston and New England region,

USA• SAPA-GP (Greater Philadelphia Chapter): Philadelphia and other

Pennsylvania areas, USA• SAPA-MW (Mid-West Chapter): Illinois and Indiana, USA• SAPA-CT (Connecticut Chapter): Connecticut, USA• SAPA-DC (DC Chapter): District of Columbia and Maryland, USA• SAPA-China: Zhengzhou and Beijing, China

Professional Expertise of SAPA Members• Drug discovery, research and development• Preclinical and clinical research and development• Application and registration of new drug and biologics to the US FDA• Production and manufacture of pharmaceuticals and biological

products• Commercial and marketing of pharmaceutical and biological products• Generic product development and technology• Clinical Diagnostics and Precision Medicine


SAPA Annual Conferences in the Recent Years

Upcoming SAPA Major EventsOctober 14 – 15: SAPA-China Annual Conference

October 15 – 16: SAPA-NE and SAPA-CT Joint Annual Conferencehttps://www.sapa-neweb.org/events/2021ac

https://www.sapa-neweb.org/events/2021ac


SAPA MissionAs a global organization, SAPA’s mission is:• To promote the advancement of pharmaceutical science and biotechnology• To contribute to public health education• To promote entrepreneurship, healthcare investment and business cooperation• To foster the career growth of pharmaceutical professionals

Sino-American PharmaceuticalProfessionalsAssociation

Follow SAPA on:

Website: https://sapaweb.org

WeChat: SAPA

LinkedIn: SAPA-HQ

Documents

2021 SAPA Annual Conference Building a Healthier Future